Use of thromboxane-a2-receptor antagonists for the...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/19 (2006.01) A61K 31/00 (2006.01) A61K 31/557 (2006.01)

Patent

CA 2076005

2076005 9211005 PCTABS00014 The use of thromboxane (TX) A2 receptor antagonists in the manufacture of medicaments for the prevention degenerative changes in the penile tissue is described. The major changes observed in the degeneration of the penile tissue, which give rise a varying degree of insufficiency of the erectile tissue, are the atrophy of the cavernous bodies, cell nucleous degeneration and myofilament degradation. Thromboxane A2 antagonists, particularly daltroban (4-(2-(4-chlorophenyl)-sulphonylaminoethyl)phenyl acetic acid) help reduce these degenerative changes.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of thromboxane-a2-receptor antagonists for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of thromboxane-a2-receptor antagonists for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of thromboxane-a2-receptor antagonists for the... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1443654

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.